Prelude Therapeutics IncPRLDEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| OrbiMed Advisors LLC | 28.60% | 15.7M | — | 2023-05-24 |
| Baker Bros. Advisors LP | 24.30% | 10.2M | ▲ +4.80pp | 2023-12-13 |
| Krishna Vaddi | 11.10% | 4.9M | — | 2024-02-12 |
| OF ABOVE PERSONS | 9.85% | 4.1M | ▲ +2.17pp | 2024-02-12 |
| FMR LLC | 0.63% | 264.7K | — | 2024-01-10 |
| UBS Group AG | 0.00% | — | — | 2024-02-13 |
Insider Transactions
Net 90d: +$25.00M · buys $25.00M / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-04-21 | ORBIMED ADVISORS LLC | Director | Buy (open market) | 1.69M | $4.44 | $7.50M |
| 2026-04-21 | ORBIMED ADVISORS LLC | Director | Buy (open market) | 1.13M | $4.44 | $5.00M |
| 2026-04-21 | Bonita David P | Director | Buy (open market) | 1.69M | $4.44 | $7.50M |
| 2026-04-21 | Bonita David P | Director | Buy (open market) | 1.13M | $4.44 | $5.00M |
1–4 of 4